Recent Updates
Recently added Catalysts
AXGN Positive Sentiment

Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences

Tuesday, February 17, 2026 BiopharmaWatch Research 2 min read
Add on Google
Key Takeaway: Axogen, Inc. has announced its participation in three upcoming investor conferences, including the Raymond James 47th Annual Institutional Investors Conference, the Leerink Global Healthcare Conference, and the Citizens Life Sciences Conference. These events will feature presentations and fireside chats, allowing management to engage with investors. Webcast links for the events are provided for live access and replays.
Price reaction · baseline $33.23 (2026-02-13 close) · hit pre-market · clean, no other AXGN news in the window
day 0 close · peak
+4.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Axogen is participating in multiple investor conferences, indicating strong investor interest.
  • The company is positioned as a leader in innovative surgical solutions for nerve repair.
  • Management's engagement through presentations and meetings suggests transparency and proactive communication.

Full Press Release Details

ALACHUA, Fla. and TAMPA, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that management is scheduled to participate in three upcoming investor conferences:
Raymond James 47th Annual Institutional Investors ConferenceParticipation: Presentation and 1x1 investor meetingsDate/Time: Presentation Tuesday, March 3, 2026, 3:25 PM ETWebcast Link:Raymond James/Axogen Presentation
Leerink Global Healthcare ConferenceParticipation: Fireside Chat and 1x1 investor meetingsDate/Time: Fireside Chat Monday, March 9, 2026, 1:00 PM ETWebcast Link:Leerink/Axogen Fireside Chat
The Citizens Life Sciences ConferenceParticipation: Fireside Chat and 1x1 investor meetingsDate/Time: Fireside Chat Tuesday, March 10, 2026, 12:30 PM ETWebcast Link:Citizens/Axogen Fireside Chat
Webcast events can be accessed live through theInvestorspage atwww.axogeninc.com. For those unable to listen to the live broadcast, the replay will be archived for 90 days and available on the Investors page atwww.axogeninc.com.

About Axogen

Axogen (Nasdaq: AXGN) is focused on the science, development and commercialization of technologies for peripheral nerve repair. With a mission to make nerve repair the expected standard of care, Axogen advances the field through research, education, and collaboration with surgeons and healthcare providers across a global network.
Axogen’s product portfolio includes Avance® (acellular nerve allograft-arwx), Avance® Nerve Graft, Axoguard Nerve Connector®, Axoguard Nerve Protector®, Axoguard HA+ Nerve Protector™, Axoguard Nerve Cap®, and Avive+ Soft Tissue Matrix™.​

Frequently Asked Questions

What conferences will Axogen participate in?

Axogen will participate in the Raymond James, Leerink Global Healthcare, and Citizens Life Sciences conferences.

When is Axogen's presentation at the Raymond James conference?

Axogen's presentation at the Raymond James conference is scheduled for March 3, 2026, at 3:25 PM ET.

How can investors access the conference webcasts?

Investors can access the webcasts live through Axogen's Investors page on their website.

What is Axogen's focus in the healthcare sector?

Axogen focuses on developing and marketing surgical solutions for peripheral nerve repair.

ShareAdd on Google
Tags: AXGN Viatris Investor Conferences Healthcare Axogen investor conferences peripheral nerve repair healthcare
Last updated: Feb 17, 2026

Biotech snapshot

Cash runway
$111M liquidity · $0M/mo burn
Low dilution risk
Lead asset
Processed Nerve AllograftPhase 3
Peripheral Nerve Discontinuities →